During the past decade, Legacy Cancer Institute Medical Oncology and Day Treatment conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 2 clinical trials were completed, i.e. on average, 8.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 2 clinical trials were completed. i.e. 15.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Legacy Cancer Institute Medical Oncology and Day Treatment" #1 sponsor was "National Cancer Institute (NCI)" with 11 trials, followed by "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "NRG Oncology" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "SWOG Cancer Research Network" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Legacy Cancer Institute Medical Oncology and Day Treatment" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Legacy Cancer Institute Medical Oncology and Day Treatment" are "Invasive Breast Carcinoma" (4 trials), "Anatomic Stage II Breast Cancer AJCC v8" (2 trials), "Anatomic Stage IIA Breast Cancer AJCC v8" (2 trials), "Anatomic Stage IIB Breast Cancer AJCC v8" (2 trials) and "Anatomic Stage IIIA Breast Cancer AJCC v8" (2 trials). Many other conditions were trialed in "Legacy Cancer Institute Medical Oncology and Day Treatment" in a lesser frequency.

Most popular intervention types in "Legacy Cancer Institute Medical Oncology and Day Treatment" are "Drug" (18 trials), "Other" (17 trials), "Radiation" (11 trials), "Procedure" (10 trials) and "Biological" (9 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (11 trials), "Questionnaire Administration" (10 trials), "Biospecimen Collection" (7 trials), "Radiation Therapy" (7 trials) and "Laboratory Biomarker Analysis" (5 trials). Other intervention names were less common.

The vast majority of trials in "Legacy Cancer Institute Medical Oncology and Day Treatment" are 21 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Legacy Cancer Institute Medical Oncology and Day Treatment". undefined are not yet recruiting, 11 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Legacy Cancer Institute Medical Oncology and Day Treatment, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Legacy Cancer Institute Medical Oncology and Day Treatment, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".